Active, Not Recruiting
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
NCT07016412
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- SEC Clinical Research, LLC Dothan, Alabama, United States
- Elite Clinical Studies, LLC Phoenix, Arizona, United States
- Tucson Clinical Research Institute Tucson, Arizona, United States
- Downtown LA Research Center Inc - ClinEdge Los Angeles, California, United States